INTRANAZAL'NYE GLYuKOKORTIKOSTEROIDY V LEChENII PATsIENTOV S POLIPOZNYM RINOSINUSITOM


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article summarizes the current state of the problem of polypoid rhinosinusitis. The potentials for the use of intranasal glucocortico-steroids in the treatment of such patients are discussed. A number of advantages of budesonide are characterized by a pharmacological parameters, allowing effective and safe control of clinical symptoms of polypoid rhinosinusitis.

Full Text

Restricted Access

References

  1. Сакович А.Р. Синуситы: клинико-эпидемиологический анализ. 2009. Доступно на: http://bsmu.by/index.php?option=com_ content&view=artide&id= 1603:2009-10-13-09-17-50&catid=116:32009&itemid=196
  2. Desrosiers M., Evans G.A., Keith P.K., et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin. immunol. 2011;7(1):2.
  3. Fokkens W.J, Lund V.J., Mullol J. et al. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2007;45(20):1-139.
  4. Fokkens W.J., Lund V.J., Mullol J., et al., European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2012;50(23):1-299.
  5. Крюков А.И., Туровский А.Б., Сединкин А.А. Диагностика и лечение полипозного синусита. РМЖ 2011;6:377-80.
  6. Княжеская Н.П., Чучалин А.Г. Ингаляционные глюкокортикостероиды (ИГКС) - основа противовоспалительной терапии бронхиальной астмы. Эффективность, безопасность и области применения суспензии Пульмикорт (будесонид). РМЖ. 2008;22:1515-19.
  7. Brattsand R., Miller-Larsson A. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity. Clin. Ther. 2003;25:28-41.
  8. Derom E. et al. Systemic Effects of inhaled Fluticasone Propionate and Budesonide in Adult Patients with Asthma. Am. J. Respir. Crit. Care Med. 1999;160:157-61.
  9. Kallen B., Rydhstroem H., Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93(3):392-95.
  10. Miller-Larsson A., et al. Reversible fatty acid conjugation of budesonide. Novel Mechanism for Prolonged Retention of Topically Applied Steroid in Airway Tissue. Drug Metabolism and Disposition. 1998;26: 623-30.
  11. Miller-Larsson A., et al. Prolonged Airway Activity and improved Selectivity of Budesonide Possibly Due to Esterification. Am. J. Respir. Crit. Care Med. 2000;162:1455-61.
  12. Pedersen S., O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroides in asthma. Allergy. 1997;52(Suppl. 39):1-34.
  13. Белоусов Ю.Б., Моисеев В.С., Лепахин В.К. Клиническая фармакология и фармакотерапия. М., 1997.
  14. Сергеев П.В., Галенко-Ярошевский П.А., Шимановский Н.Л. Очерки биохимической фармакологии. М., 1996.
  15. Kallen B., Rydhstroem H., Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol. 1999;93:392-95.
  16. Kim K.T., Rabinovitch N., Uryniak T., Simpson B., O'Dowd L., Casty F. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Ann Allergy Asthma immunol. 2004;93:61-7.
  17. FDA Pregnancy Labeling Task Force http:// www.fda.gov/cder/handbook/categc.htm
  18. Yawn B. Knudtson M. Treating asthma and comorbid allergic rhinitis in pregnancy. J. Am. Board Fam. Med. 2007;20:289-98.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies